HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of Ustekinumab on Extraintestinal Diseases in Refractory Crohn's Disease.

AuthorsAntonio Tursi, Giammarco Mocci, Giovanni Maconi
JournalJournal of Crohn's & colitis (J Crohns Colitis) Vol. 15 Issue 8 Pg. 1399-1400 (Aug 02 2021) ISSN: 1876-4479 [Electronic] England
PMID33580249 (Publication Type: Letter)
Chemical References
  • Immunologic Factors
  • Ustekinumab
Topics
  • Adolescent
  • Adult
  • Crohn Disease (complications, drug therapy)
  • Female
  • Follow-Up Studies
  • Humans
  • Immunologic Factors (therapeutic use)
  • Induction Chemotherapy
  • Male
  • Middle Aged
  • Treatment Outcome
  • Ustekinumab (therapeutic use)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: